Send to

Choose Destination
ACS Chem Neurosci. 2019 Feb 20;10(2):945-953. doi: 10.1021/acschemneuro.8b00454. Epub 2019 Jan 17.

Impact of Dopamine Oxidation on Dopaminergic Neurodegeneration.

Author information

Laboratory of Molecular Neuropathology, Jiangsu Key Laboratory of Neuropsychiatric Disorders & Department of Pharmacology, College of Pharmaceutical Sciences , Soochow University , Suzhou , Jiangsu 215123 , China.


Parkinson's disease (PD) is the second most common neurodegenerative disease. The characteristic feature of PD is the progressive degeneration of the dopaminergic (DAergic) neurons in the substantia nigra (SN). DAergic neurons in the SN accumulate black and insoluble membrane structures known as neuromelanin during aging. The oxidation of dopamine (DA) to form neuromelanin generates many o-quinones, including DA o-quinones, aminochrome, and 5,6-indolequinone. The focus of this review is to discuss the role of DA oxidation in association with PD. The oxidation of DA produces oxidative products, inducing mitochondrial dysfunction, impaired protein degradation, α-synuclein aggregation into neurotoxic oligomers, and oxidative stress, in vitro. Recent studies have demonstrated that the DA content is critical for both DJ-1 knockout and A53T α-synuclein transgenic mice to develop PD pathological features, providing evidence for DA action in PD pathogenesis in vivo. The effects of L-DOPA, as the most effective anti-PD drug, are also briefly discussed.


L-DOPA; Parkinson’s disease; dopamine; dopamine o-quinone; neuromelanin; oxidative stress; α-synuclein

Supplemental Content

Full text links

Icon for American Chemical Society
Loading ...
Support Center